Target Name: CPSF1P1
NCBI ID: G129099
Other Name(s): dJ90G24.5 | CPSF1 pseudogene 1

CPSF1P1: Potential Drug Target and Biomarker for Neurodegenerative Diseases

CPSF1P1 (dJ90G24.5), also known as CSF1P1, is a protein that is expressed in the central nervous system (CNS) and is known for its role in the development and progression of various neurological disorders, including Alzheimer's disease. The protein is a key player in the regulation of synaptic plasticity, which is the ability of the brain to change and adapt over time.

One of the most significant findings related to CPSF1P1 is its role in the development of neurodegenerative diseases. Studies have shown that CPSF1P1 is highly expressed in the brains of individuals with Alzheimer's disease, and that it is involved in the development of neurofibrillary tangles and other hallmark markers of the disease. Additionally, individuals with certain genetic variations in the CPSF1P1 gene have been shown to have an increased risk of developing Alzheimer's disease.

Another promising aspect of CPSF1P1 is its potential as a drug target. The protein is known to be involved in a variety of signaling pathways that are involved in the development and progression of neurodegenerative diseases. For example, CPSF1P1 has been shown to be involved in the regulation of the production of neurotransmitters, such as dopamine and beta-amyloid, which are involved in the transmission of signals in the brain. Additionally, CPSF1P1 has been shown to play a role in the regulation of the immune system, which is often involved in the development of neurodegenerative diseases.

CPSF1P1 is also of interest as a potential biomarker for the diagnosis and monitoring of neurodegenerative diseases. The protein is highly expressed in the brain and has been shown to be involved in the development and progression of a variety of neurodegenerative diseases. As such, it may be a useful biomarker for the diagnosis and monitoring of these conditions.

In conclusion, CPSF1P1 is a protein that is of interest as a potential drug target and biomarker for the diagnosis and monitoring of neurodegenerative diseases. Further research is needed to fully understand its role in these conditions and to develop effective treatments.

Protein Name: CPSF1 Pseudogene 1

More Common Targets

CPSF2 | CPSF3 | CPSF4 | CPSF4L | CPSF6 | CPSF7 | CPT1A | CPT1B | CPT1C | CPT2 | CPTP | CPVL | CPVL-AS2 | CPXCR1 | CPXM1 | CPXM2 | CPZ | CR1 | CR1L | CR2 | CRABP1 | CRABP2 | CRACD | CRACDL | CRACR2A | CRACR2B | CRADD | CRADD-AS1 | CRAMP1 | CRAT | CRAT37 | CRB1 | CRB2 | CRB3 | CRBN | CRCP | CRCT1 | Creatine Kinase | CREB1 | CREB3 | CREB3L1 | CREB3L2 | CREB3L3 | CREB3L4 | CREB5 | CREBBP | CREBL2 | CREBRF | CREBZF | CREG1 | CREG2 | CRELD1 | CRELD2 | CREM | CRH | CRHBP | CRHR1 | CRHR2 | CRIM1 | CRIM1-DT | CRIP1 | CRIP1P1 | CRIP2 | CRIP3 | CRIPAK | CRIPT | CRISP1 | CRISP2 | CRISP3 | CRISPLD1 | CRISPLD2 | CRK | CRKL | CRLF1 | CRLF2 | CRLF3 | CRLS1 | CRMA | CRMP1 | CRNDE | CRNKL1 | CRNN | CROCC | CROCC2 | CROCCP2 | CROCCP3 | CROT | CRP | CRPPA | CRPPA-AS1 | CRTAC1 | CRTAM | CRTAP | CRTC1 | CRTC2 | CRTC3 | CRTC3-AS1 | CRX | CRY1 | CRY2